Novanta Inc. (Nasdaq: NOVT), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that the Company's Chairman of the Board, Stephen W. Bershad, has sold 500,000 common shares, representing approximately 22% of his holdings in the Company. Mr. Bershad will continue in his role as Chairman of the Board, and continues to hold 1,808,010 shares immediately following this sale.

"I'm very proud of what our management team has accomplished over the past 7 years. Today, we have a clear vision of where we are going and the human and financial resources necessary to get there," said Mr. Bershad. "I am selling a portion of my Novanta holdings primarily for estate planning purposes. However, I intend to continue to have a significant ownership position in Novanta stock and maintain my role as Chairman of the Board," Mr. Bershad added. "I have never been more optimistic about the Company's ability to accomplish its strategic growth objectives," concluded Mr. Bershad.

About Novanta

Novanta is a leading global supplier of core technology solutions that give healthcare and advanced industrial original equipment manufacturers ("OEMs") a competitive advantage. We combine deep proprietary technology expertise in photonics, vision, and precision motion with a proven ability to solve complex technical challenges. This enables Novanta to engineer core components and sub-systems that deliver extreme precision and performance, tailored to our customers' demanding applications. The driving force behind our growth is the team of innovative professionals who share a commitment to innovation and customer success. Novanta's common shares are quoted on Nasdaq under the ticker symbol "NOVT."

More information about Novanta is available on the Company's website at www.novanta.com.